Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin

✍ Scribed by Anastasi, Sergio; Sala, Gianluca; Huiping, Chen; Caprini, Elisabetta; Russo, Giandomenico; Iacovelli, Stefano; Lucini, Fabiana; Ingvarsson, Sigurdur; Segatto, Oreste

• Book ID: 110069707
• Publisher: Nature Publishing Group
• Year: 2005
• Tongue: English
• Weight: 399 KB
• Volume: 24
• Category: Article
• ISSN: 0950-9232
• DOI: 10.1038/sj.onc.1208658